Diseases, Conditions, Syndromes

New hepatitis C drug shows potential in phase 2 trials

The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological ...

Medical research

New mouse model for hepatitis C

Hepatitis C affects about three million people in the U.S. and is a leading cause of chronic liver disease, so creating a vaccine and new treatments is an important public health goal. Most research to date has been done ...

Diseases, Conditions, Syndromes

Okla. says hepatitis C was spread at dental clinic

Oklahoma health officials say a dentist's office shut down for unsafe practices last spring is responsible for the first known transmission of hepatitis C from one dental patient to another.

Diseases, Conditions, Syndromes

Women have higher rate of spontaneous clearance of hepatitis C virus

A study of patients infected with acute hepatitis C virus (HCV) infection found that women had higher rates of spontaneous viral clearance—undetectable levels of the virus without initiating drug therapy. Findings published ...

Diseases, Conditions, Syndromes

MERS-CoV treatment effective in monkeys, study finds

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more ...

Diseases, Conditions, Syndromes

Baby boomers need hepatitis C test, CDC study confirms

(HealthDay)—Baby boomers—the generation known for sex, drugs and rock and roll—are the most likely Americans to develop hepatitis C, and too many of them aren't tested until it's too late to prevent liver damage, U.S. ...

page 22 from 36